Basic nutrients
Omega-3 fatty acids
Amino acids
Minerals
Vitamins
Vitamin capsules
Liquid vitamins
Vitamin complex
Plant substances & superfoods
Antioxidants
Plant substances
Superfoods
Vital mushrooms
Functional nutrients
Enzymes & fiber
Melatonine
Probiotics
Bones, joints & muscles
Joints
Bones
Muscles
Weight loss & metabolism
Lose weight
Metabolism
Drainage
Mental health & performance
Memory & concentration
Stress, exhaustion & burnout
Mood
Sleep & fatigue
Energy
Sleep disorder
Iron deficiency
Heart health
Circulation
Heart protection
Blood pressure
Cholesterol
Women's health
Pregnancy & breastfeeding
Fertility
Hormone balance
PMS
Libido
Menopause
Recurrent cystitis
Men's health
Libido & erectile dysfunction
Prostate
Stomach & intestine
Intestinal cleansing & build-up
Digestive problems
Bloating
Heartburn
Hemorrhoids
Parasites
Beauty
Skin
Hair
Connective tissue
Liver health
Detoxification
Liver protection
Immune system
Strenghten the immune system
Allergy
Blood sugar
Eyes & eyesight
Inflammations
Histamine Intolerance
Pain
Longevity & cellular regeneration
Acid-base balance
Value packs
Card Value:
Qty
Discount:
You save:
Referral discount:
Grand Total:
Neu
Atopic dermatitis is rarely experienced as one single sensation. Tightness builds. Itching takes over attention. Scratching becomes a reflex long before sleep or focus returns. Topical measures can quieten a flare, yet many families recognise the pattern: when the visible inflammation (the body’s defence reaction, harmful when it becomes chronic) settles, the underlying tendency too often remains. That is the editorial starting point here. Instead of trying to outpace each flare with a stronger topical, the routine is constructed around three foundations that sit beneath the surface: barrier lipids, fatty‑acid conversion and the gut–skin axis.
Think of the epidermis as brickwork. Keratinocytes are the bricks; intercellular lipids are the mortar. In atopic skin, the mortar is thinner and more permeable. Water loss increases; irritants enter more freely; immune cells encounter more signals than usual. The visible itch and redness are the end of that chain, not its beginning. A more complete intervention therefore needs to reach the lipid matrix itself, ensure the body can generate the relevant lipid mediators and calm the background immune reactivity fed by the intestinal environment.
This is not a one‑ingredient attempt to “fix” a complex condition. It is a deliberately layered routine: Evening Primrose Oil (EPO) for gamma‑linolenic acid as a direct barrier‑lipid input; zinc picolinate to support the desaturase step that sits upstream of GLA derivatives; and a defined probiotic component to help steady the intestinal ecosystem that influences systemic immune tone. The logic is simple: one level stabilises structure, one supports the pathway that supplies regulatory mediators and one tends the environment that shapes the immune conversation.
Everyday translation first. Skin that feels tight after washing, becomes flaky by late afternoon or marks easily after scratching is not “just dry”. In atopic dermatitis the stratum corneum commonly shows reduced ceramides and altered fatty‑acid composition. Transepidermal water loss rises, microfissures form and the epidermis becomes an easier landscape for discomfort. Emollients can cover the surface. But structural lipids also have to arrive from within.
Evening Primrose Oil is one of the few botanical sources with meaningful gamma‑linolenic acid (GLA) content. GLA is elongated to dihomo‑gamma‑linolenic acid (DGLA), from which the body forms series‑1 prostaglandins and other lipid mediators with inflammation‑modulating properties. Two effects are relevant to the atopic picture: incorporation of GLA‑derived fatty acids into the barrier lipid matrix, which helps reduce water loss and surface roughness; and provision of precursor material for mediators that guide an over‑active response back toward a steadier baseline. Neither effect is an instant change. They are part of normal physiology building itself over time.
Key point: GLA belongs to the structural chemistry of the barrier and to the body’s own mediator balance — that is why EPO is positioned at the structural level of this routine rather than as a superficial cosmetic idea.
Linoleic acid (LA, 18:2n‑6) is desaturated by delta‑6‑desaturase to GLA (18:3n‑6), elongated to DGLA (20:3n‑6) and then converted via cyclooxygenase and lipoxygenase pathways into eicosanoids such as PGE1. In atopic skin, reduced LA‑derived ceramides and impaired fatty‑acid handling are frequently described. Where the desaturase step is rate‑limiting — a step that relies on micronutrients including zinc as a cofactor — supplying GLA directly provides substrate downstream of that bottleneck. DGLA also competes with arachidonic‑acid–derived pathways, which further shapes the mediator profile toward less pro‑inflammatory signalling.
Decision anchor: EPO is not framed here as a quick topical alternative, but as a repeating input into the lipid matrix and mediator landscape. Routine matters more than any single capsule.
It is tempting to treat skin nutrition as a list of oils. The pathway is less romantic and more mechanistic. The delta‑6‑desaturase step that turns linoleic acid toward GLA does not run on enthusiasm. It requires cofactors, among them zinc. When micronutrient status is marginal, the body can prioritise other processes and leave skin functions under‑served. That shows up as a thinner barrier, slower re‑epithelialisation and an inflammatory tone that feels harder to settle.
Zinc contributes to normal macronutrient metabolism (the way the body turns food into energy and building material), protein synthesis and maintenance of normal skin. Those are the authorised, ordinary physiological roles — not clinical claims. In atopic conditions, lower zinc status has been reported in some cohorts compared with non‑atopic controls. Chronic scratching and low‑grade inflammation also increase demand. The routine therefore includes zinc picolinate, a form selected for practical reasons rather than label length: it is a chelated form that is widely used where good bioavailability (how much of a nutrient the body can actually absorb and use) is sought.
Key point: Without adequate zinc, the pathway that supplies GLA‑derived mediators can remain a bottleneck. The routine therefore pairs substrate (EPO) with cofactor (zinc).
Zinc sits across hundreds of enzymes (proteins that set the body's chemical processes in motion), transcription factors and structural proteins. In skin, it supports keratinocyte proliferation and differentiation, modulates immune signalling and participates in antioxidant (it protects cells from attack by aggressive molecules) defence. Critically for the EPO level of this routine, zinc is required for the normal function of desaturases that control the availability of GLA and its elongation products. That is not a medical treatment claim; it is an explanation for why the oil‑only approach can underperform if the enzymatic step remains under‑resourced.
Decision anchor: Substrate without cofactor, or cofactor without substrate, are both incomplete frames for a barrier‑lipid problem.
Rashes appear on the surface. The immune tone that helps produce them often does not begin there. Around 70% of immune cells are associated with the gut. The intestinal mucosa and its resident microbes continuously exchange signals that shape the balance between tolerance and response. When that balance leans toward heightened reactivity — a pattern documented in subsets of atopic patients — the skin can become an outlet for that systemic conversation.
Probiotics (live bacteria that support the gut flora) are not a silver bullet. They are a way of modifying the environment in which immune decisions are made. Selected Lactobacillus and Bifidobacterium strains can support short‑chain fatty‑acid production, strengthen mucosal barrier (the protective lining of the gut and bladder) function and influence cytokine profiles. The point is not that a capsule “treats eczema”. The point is that the intestinal context matters to skin more than a topical tube can ever show.
Key point: The probiotic level is included because recurring atopic patterns are often not skin‑only stories. Where the gut is in constant alarm, the skin continues to hear it.
Decision anchor: Structural lipids and cofactors work best when the immune environment is not constantly being pushed toward reactivity.
Multi‑ingredient capsules promise convenience. Physically, they also promise a trade‑off: capsule space is finite. An oil such as Evening Primrose needs volume to deliver a meaningful GLA amount. Zinc requires a defined daily dose. Probiotics need colony‑forming units at levels that make sense for the strains being used. Squeezing all three into a single small format typically means each is present only in a token amount.
Herbano uses three standalone products deliberately. Each has its own role and can be judged on its own formulation and amount. The result is not one crowded label with many names competing for space, but a routine in which every component keeps its purpose and dose.
In editorial terms:
Together, the trio reads as a structured routine rather than a random pack: three products, three defined levels, one coherent reason they belong in the same plan.
Mechanism recap. EPO provides GLA directly, bypassing the rate‑limiting desaturase step. GLA is elongated to DGLA and participates in the generation of series‑1 prostaglandins such as PGE1. Incorporation into epidermal lipids can improve water‑holding capacity and surface feel over the natural renewal cycle (≈28 days).
The editorial dose question is not “how much oil”, but “how much GLA”. The pack’s EPO capsule provides 1000 mg Evening Primrose Oil with 10% GLA = 100 mg GLA per capsule. The routine logic is to maintain a repeating GLA input over multiple skin‑renewal cycles rather than expecting an immediate day‑to‑day change. Consistency is central to lipid incorporation.
NRVs are reference points for general nutrition rather than direct measures of formulation relevance for non‑NRV nutrients such as GLA. The comparison that matters is with amounts examined in human studies and with the physiological role being described. The declared GLA content per capsule provides an easy anchor for that comparison.
Anyone building a routine around barrier lipids, particularly where skin feels tight, rough or quick to mark, can recognise why the lipid matrix needs recurrent (coming back again and again) input. That description does not diagnose a condition; it clarifies the physiological basis for including GLA as part of an atopic support plan.
GLA‑containing oils are generally well tolerated in food‑supplement amounts. Where side effects are discussed, they are typically mild and gastrointestinal in nature. If a list is useful for orientation, it should remain practical rather than alarmist:
These are not expected effects; they are included here because decision‑relevant information should not hide in fine print.
Mechanism recap. Zinc is woven through normal keratinocyte turnover, protein synthesis, immune modulation and as a cofactor for desaturase enzymes that help determine the availability of GLA and downstream mediators. Where zinc status is marginal, the enzyme step can remain rate‑limiting — an argument for pairing zinc with the lipid substrate rather than expecting EPO to tell the whole story by itself.
Zinc has an established daily reference value and upper level considerations in public health contexts. The product label specifies the exact amount per serving and the intended daily intake for this pack’s zinc picolinate component; the routine is designed around remaining within labelled directions while sustaining intake over time. The editorial point is not to chase the highest possible milligrams. It is to ensure the cofactor is reliably present while the lipid layer is being rebuilt.
Where the barrier‑lipid story is central, zinc belongs in the conversation because it supports the enzymatic step that supplies GLA derivatives and because normal skin maintenance depends on adequate zinc status. That is a physiological frame, not a treatment claim.
Spacing zinc with food is a simple way to improve comfort for those who notice these effects.
Mechanism recap. Selected probiotic strains can help restore a more diverse, resilient gut ecosystem. Through interactions with epithelial cells and immune tissues such as Peyer’s patches, they influence cytokine balance and promote short‑chain fatty‑acid production. Butyrate and related SCFAs support mucosal integrity and can tilt systemic signalling away from a chronically heightened alert state. In atopic subjects, where immune skew and barrier issues often co‑exist, that can be a meaningful background shift.
For live cultures, the practical question is viability at the point of ingestion and in the small intestine. The pack’s probiotic capsules use a gastro‑resistant format so that live bacteria reach the gut. The exact strains and CFU amounts are specified on the label of the probiotic component; the routine logic is to maintain daily intake consistently rather than expecting a one‑off capsule to reset a complex ecosystem.
Any atopic routine that recognises the gut–skin axis will keep a place for the intestinal environment. The probiotic level is therefore about the background — the body’s decision‑making context — not an immediate topical analogue.
Such effects, where they occur, typically settle as the routine continues.
One way to visualise the routine is to place the three components along a chain:
When any one of those levels is missing, the others can feel less effective. Substrate without cofactor can be like bricks without mortar. Cofactor without substrate can be like good tools without materials. Both without a calmer environment can be like building during a storm. The commercial value of the bundle is therefore the logic of the combination: each product has its own job, and the jobs are different enough that putting them into one capsule would not only reduce their amounts but also collapse their reasons for being included.
Supplements can look similar from the front of the pack. The differences live in dose, declared actives, capsule format and evidence. This routine makes those decisions visible:
Bold takeaway: Each product can be read and judged on its own merits — amount, form and purpose are not hidden behind an all‑in‑one promise.
Readers who recognise a pattern of persistently tight, easily irritated skin that responds to topicals only while they are used may wish to frame the issue at a deeper level: what the barrier is built from, whether the supply line for relevant mediators is open and what the immune background looks like. That is the intended audience for the logic here. It is an editorial orientation, not a diagnostic instruction.
Barrier‑lipid stories are measured in weeks, not days. The stratum corneum renews roughly every four weeks. Evidence‑consistent expectations focus on multiple renewal cycles with steady intake rather than day‑to‑day fluctuations. Zinc status and gut‑ecosystem adjustments also lean toward longer horizons than a single weekend. The routine is therefore presented as a steady habit rather than as an emergency measure.
Is this “more” than taking a single product? Not necessarily more in number for its own sake — more aligned with the problem’s layers. The barrier, the enzymatic supply and the immune environment are distinct. One product cannot occupy all three levels meaningfully without cutting corners on amounts or formats.
The routine remains within normal food‑supplement use. General considerations included for completeness:
These notes are not exhaustive; they are the kind of pragmatic orientation a health‑literate reader expects to see up front.
It is easy to buy another cream. It is harder — and more useful — to ask what the skin needs in order to become less dependent on one. Barrier lipids need recurring material. The enzyme that supplies their regulatory derivatives needs its cofactor. The immune background needs a calmer conversation. That is the structure this pack offers. It is not a claim to solve a clinical condition. It is a clearer way of thinking about a stubborn everyday problem, expressed as three separate products so that each level can be done properly.
This is a three‑part routine. Each component has its own label with the exact serving amount and timing. The general, practical guidance below is provided to help plan a coherent daily pattern without suggesting clinical use or replacing the individual product directions.
Barrier‑lipid incorporation, zinc‑dependent enzymatic pathways and changes in the gut environment all lean on regular intake over weeks rather than a particular hour of the day.
The routine is designed around the labelled daily servings of each product. Do not exceed those amounts. Food supplements are not a substitute for a varied, balanced diet and a healthy lifestyle. Keep out of reach of children. Store the products closed, cool, dry and away from direct sunlight.
Do not exceed the recommended daily dose.
Food supplements should not be used as a substitute for a varied and balanced diet and a healthy lifestyle.
Store in a cool, dry place away from light. Keep out of reach of young children.
Composition:
The pack contains 3 separate preparations. Composition and amounts for each preparation:
Composition Evening primrose oil capsules:
Organic evening primrose oil, glycerol, water, natural vitamin E (D-alpha-tocopherol), organic porcine gelatine (capsule shell)
Quantities per capsule:
Composition Zinc picolinate capsules:
Calcium ascorbate, zinc picolinate, hydroxypropyl methylcellulose (vegan capsule shell)
Composition probiotics (live bacteria that support the gut flora) capsules:
Organic inulin, hydroxypropyl methylcellulose (vegan capsule shell), 10 viable lactic acid cultures*
*B. breve, B. bifidum, B. lactis, B. longum, L. acidophilus, L. casei, L. paracasei, L. plantarum, L. rhamnosus, S. thermosphilus
Free from gluten, lactose, artificial flavors and preservatives.
Suitable for vegans.
Store in the refrigerator.
Number of live lactic acid bacteria per recommended daily intake:
Because the atopic picture commonly spans three levels at once: the barrier lipid matrix, the enzymatic supply of regulatory lipid mediators and the immune environment shaped by the gut. One product cannot occupy all three layers at meaningful amounts without compromise. Separate capsules keep each role clear and each amount meaningful.
No. The argument here is not generic fat intake. It is the provision of a specific fatty acid, gamma‑linolenic acid, at a declared amount. GLA is relevant to barrier chemistry and to the generation of series‑1 lipid mediators. That specificity is the point.
Zinc has several salt forms. Picolinate is used widely in supplements for its practical absorption characteristics. The routine uses a standalone zinc picolinate capsule so the cofactor role is addressed without crowding oil or live cultures into the same small format.
Barrier‑lipid stories take time — epidermal renewal is roughly four weeks. A pragmatic window to assess is multiple renewal cycles with consistent intake. That time frame aligns with the mechanisms described and with trial durations that reported changes.
Yes in principle, but spacing is the practical rule: separate probiotics (live bacteria that support the gut flora) and antibiotics by several hours. This is common pharmacy guidance to reduce the likelihood that the antibiotic will inactivate the live cultures in the gut. Follow any medical advice specific to the antibiotic being used.
Most people tolerate these products well. Where effects occur, they are usually mild and transient. Typical examples include:
No. This is a nutritional routine, not a medical treatment. Severe or infected flares require medical assessment. The routine is designed to support underlying skin physiology and the gut–skin axis between and beyond acute episodes.
Sources (in English):
Senapati S, Banerjee S, Gangopadhyay DN (2008). Evening primrose oil in atopic dermatitis: a randomised, double‑blind, placebo (a dummy treatment used for comparison)‑controlled study. Indian Journal of Dermatology, Venereology and Leprology. doi:10.4103/0378-6323.42944 https://doi.org/10.4103/0378-6323.42944
Muggli R (2005). Systemic evening primrose oil improves the biophysical skin parameters of healthy adults. International Journal of Cosmetic Science. doi:10.1111/j.1467-2494.2005.00272.x https://doi.org/10.1111/j.1467-2494.2005.00272.x
Fan Y‑Y, Chapkin RS (1998). Importance of dietary gamma‑linolenic acid in human health and nutrition. The Journal of Nutrition. doi:10.1093/jn/128.9.1411 https://doi.org/10.1093/jn/128.9.1411
Miller AL (1996). Essential fatty acids and skin health. Alternative Medicine Review https://pubmed.ncbi.nlm.nih.gov/8974314/
Kim JE, Yoo SR, Jeon IH, et al. (2014). Zinc deficiency in children with atopic dermatitis: a hospital‑based case‑control study. Journal of Pediatric Research. doi:10.4274/Jpr.85063 https://doi.org/10.4274/Jpr.85063
Lansdown ABG, Mirastschijski U, Stubbs N, Scanlon E, Agren MS (2007). Zinc in wound healing: theoretical, experimental, and clinical aspects. Wound Repair and Regeneration. doi:10.1111/j.1524-475X.2007.00225.x https://doi.org/10.1111/j.1524-475X.2007.00225.x
Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E (2001). Probiotics (live bacteria that support the gut flora) in primary prevention of atopic disease: a randomised placebo‑controlled trial. The Lancet. doi:10.1016/S0140-6736(00)04171-8 https://doi.org/10.1016/S0140-6736(00
Cuello‑García CA, Brożek JL, Fiocchi A, et al. (2015). Probiotics for the prevention of allergy: a systematic review and meta‑analysis of randomized controlled trials. The Journal of Allergy and Clinical Immunology. doi:10.1016/j.jaci.2014.12.019 https://doi.org/10.1016/j.jaci.2014.12.019
Floch MH, Walker WA, Sanders ME, et al. (2015). Recommendations for probiotic use—2015 update: proceedings and consensus opinion. Journal of Clinical Gastroenterology. doi:10.1097/MCG.0000000000000420 https://doi.org/10.1097/MCG.0000000000000420
Byrd AL, Belkaid Y, Segre JA (2018). The human skin microbiome (the whole community of bacteria living in the gut). Nature Reviews Microbiology. doi:10.1038/s41579-018-0091-9 https://doi.org/10.1038/s41579-018-0091-9
Jensen JM, Proksch E (2009). The skin’s barrier. Giornale Italiano di Dermatologia e Venereologia https://pubmed.ncbi.nlm.nih.gov/19773762/
Sampson HA (2004). Update on food allergy. Journal of Allergy and Clinical Immunology. doi:10.1016/j.jaci.2004.06.015 https://doi.org/10.1016/j.jaci.2004.06.015
Thank you for your feedback. Your review will be released shortly.
Atopic Dermatitis Support Pack by Herbano® – Evening Primrose Oil + Zinc + Probiotics